With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...

Abbott Laboratories (NYSE:ABT) recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from ...

Abbott Laboratories closed 6.08% below its 52-week high of $141.23, which the company reached on March 4th.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

We recently published a list of Diamond Hill Capital Stock Portfolio: Top 10 Stock Picks. In this article, we are going to ...

McDonald's, Abbott Laboratories, O'Reilly Automotive and MIND Technology are part of the Zacks top Analyst Blog.

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...